Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Satirapoj, Bancha ^a   Tassanasorn, Surat ^a   Charoenpitakchai, Mongkon ^a   Supasyndh, Ouppatham ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; TRANSCRIPTION FACTOR RUNX2; TRIACYLGLYCEROL; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN;

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY INJURY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOKING; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; AGED; BIOPSY; CHEMISTRY; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; EPIDEMIOLOGY; GLOMERULUS; KIDNEY FUNCTION TEST; KIDNEY TUBULE; MIDDLE AGED; PATHOLOGY; URINE;

ANIMALIA;

ADULT; AGED; ALBUMINURIA; BIOMARKERS; BIOPSY; CELL ADHESION MOLECULES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MIDDLE AGED; SAMPLING STUDIES;

EID: 84929485208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124055     Document Type: Article

References (24)

1. Satirapoj B, Adler SG. Comprehensive approach to diabetic nephropathy. Kidney Research and Clinical Practice. 2014; 33: 121-131.
2. Satirapoj B. Nephropathy in diabetes. Adv Exp Med Biol. 2012; 771: 107-122. PMID: 23393675.
3. Satirapoj B, Nast CC, Adler SG. Novel insights into the relationship between glomerular pathology and progressive kidney disease. Adv Chronic Kidney Dis. 2012; 19: 93-100. doi:10.1053/j.ackd.2011.12.001PMID: 22449346.
4. Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications. 1998; 12: 43-60. PMID: 9442815.
5. Pfleiderer S, Zimmerhackl LB, Kinne R, Manz F, Schuler G, Brandis M. Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of alpha 1- microglobulin and Tamm-Horsfall protein. Clin Investig. 1993; 71: 972-977. PMID: 7510155.
6. Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM, Herman WH. Does microalbuminuria predict diabetic nephropathy? Diabetes Care. 2001; 24: 1560-1566. PMID: 11522699.
7. Ito T, Suzuki A, Imai E, Horimoto N, Ohnishi T, Daikuhara Y, et al. Tornado extraction: A method to enrich and purify RNA from the nephrogenic zone of the neonatal rat kidney. Kidney Int. 2002; 62: 763-769. PMID: 12164857.
8. Satirapoj B, Wang Y, Chamberlin MP, Dai T, LaPage J, Phillips L, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant. 2012; 27: 2702-2711. doi:10.1093/ndt/gfr670PMID: 22167593.
9. Mael-Ainin M, Abed A, Conway SJ, Dussaule JC, Chatziantoniou C. Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol. 2014; 25: 1724-1736. doi:10.1681/ASN.2013060664 PMID: 24578131.
10. Satirapoj B, Witoon R, Ruangkanchanasetr P, Wantanasiri P, Charoenpitakchai M, Choovichian P. Urine periostin as a biomarker of renal injury in chronic allograft nephropathy. Transplant Proc. 2014; 46: 135-140. doi:10.1016/j.transproceed.2013.07.069 PMID: 24507039.
11. Sen K, Lindenmeyer MT, Gaspert A, Eichinger F, Neusser MA, Kretzler M, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011; 179: 1756-1767. doi:10.1016/j.ajpath.2011.06.002 PMID: 21854746.
12. Guerrot D, Dussaule JC, Mael-Ainin M, Xu-Dubois YC, Rondeau E, Chatziantoniou C, et al. Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012; 7: e31974. doi:10.1371/journal.pone.0031974 PMID: 22403621.
13. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013; 3: 136-150. PMID: 25018979.
14. Reidy K, Susztak K. Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. Am J Kidney Dis. 2009; 54: 590-593. doi:10.1053/j.ajkd.2009.07.003PMID: 19781451.
15. Ziyadeh FN. Mediators of diabetic renal disease: The case for tgf-Beta as the major mediator. J Am Soc Nephrol. 2004; 15 Suppl 1: S55-S57. PMID: 14684674.
16. Bitzer M, Sterzel RB, Bottinger EP. Transforming growth factor-beta in renal disease. Kidney Blood Press Res. 1998; 21: 1-12. PMID: 9661131.
17. Hills CE, Squires PE. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol. 2010; 31: 68-74. doi:10.1159/000256659 PMID: 19887790.
18. Oku E, Kanaji T, Takata Y, Oshima K, Seki R, Morishige S, et al. Periostin and bone marrow fibrosis. Int J Hematol. 2008; 88: 57-63. doi:10.1007/s12185-008-0095-2 PMID: 18465194.
19. Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, et al. Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006; 118: 98-104. PMID: 16815144.
20. Gordon ED, Sidhu SS, Wang ZE, Woodruff PG, Yuan S, Solon MC, et al. A protective role for periostin and TGF-beta in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy. 2012; 42: 144-155. doi:10.1111/j.1365-2222.2011.03840.x PMID: 22093101.
21. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 1999; 56: 1627-1637. PMID: 10571771.
22. Adler S, Striker LJ, Striker GE, Perkinson DT, Hibbert J, Couser WG. Studies of progressive glomerular sclerosis in the rat. Am J Pathol. 1986; 123: 553-562. PMID: 3521303.
23. Fioretto P, Steffes MW, Sutherland DE, Mauer M. Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. Kidney Int. 1995; 48: 1929-1935. PMID: 8587254.
24. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1992; 20: 1-17. PMID: 1621674.